These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2737232)

  • 1. High haemodialysis clearance of ornidazole in the presence of a negligible renal clearance.
    Horber FF; Maurer O; Probst PJ; Heizmann E; Frey FJ
    Eur J Clin Pharmacol; 1989; 36(4):389-93. PubMed ID: 2737232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.
    Merdjan H; Baumelou A; Diquet B; Chick O; Singlas E
    Br J Clin Pharmacol; 1985 Feb; 19(2):211-7. PubMed ID: 3986079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ornidazole in patients with acute viral hepatitis, alcoholic cirrhosis, and extrahepatic cholestasis.
    Taburet AM; Attali P; Bourget P; Etienne JP; Singlas E
    Clin Pharmacol Ther; 1989 Apr; 45(4):373-9. PubMed ID: 2702794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ornidazole in patients with severe liver cirrhosis.
    Taburet AM; Delion F; Attali P; Thebault JJ; Singlas E
    Clin Pharmacol Ther; 1986 Sep; 40(3):359-64. PubMed ID: 3742940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.
    Lamp KC; Freeman CD; Klutman NE; Lacy MK
    Clin Pharmacokinet; 1999 May; 36(5):353-73. PubMed ID: 10384859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of gastric elimination of ornidazole after intravenous administration in patients undergoing digestive surgery].
    Diquet B; Ghesquière F; Etienne DS; Olivero JP; Viars P
    Therapie; 1990; 45(4):307-10. PubMed ID: 2399512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of ornidazole in neonates and infants after a single intravenous infusion.
    Turcant A; Granry JC; Allain P; Cavellat M
    Eur J Clin Pharmacol; 1987; 32(1):111-3. PubMed ID: 3582464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function.
    Aweeka F; Jayesekara D; Horton M; Swan S; Lambrecht L; Wilner KD; Sherwood J; Anziano RJ; Smolarek TA; Turncliff RZ
    Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):27S-33S. PubMed ID: 10771451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin.
    Nix DE; Schultz RW; Frost RW; Sedman AJ; Thomas DJ; Kinkel AW; Schentag JJ
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():87-95. PubMed ID: 3162906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steady-state intravenous pharmacokinetics of pirenzepine in patients with differing degrees of renal dysfunction.
    Krakamp B; Tanswell P; Vogel H; Bozler G
    Eur J Clin Pharmacol; 1989; 36(1):75-8. PubMed ID: 2917593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Fillastre JP; Borsa F; Godin M
    J Antimicrob Chemother; 1983 Jul; 12(1):47-58. PubMed ID: 6619046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic studies of ornidazole in the rat, in the dog and in man.
    Schwartz DE; Jordan JC; Vetter W; Oesterhelt G
    Xenobiotica; 1979 Sep; 9(9):571-81. PubMed ID: 524917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of sisomicin in patients with normal and impaired renal function; its efficacy in urinary tract infection.
    Roth S; Naber K; Scheer M; Gruenwaldt G; Lange H
    Eur J Clin Pharmacol; 1976 Sep; 10(5):357-65. PubMed ID: 789084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of metronidazole in patients with varying degrees of renal failure.
    Houghton GW; Dennis MJ; Gabriel R
    Br J Clin Pharmacol; 1985 Feb; 19(2):203-9. PubMed ID: 3986078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of cefonicid in uraemic patients.
    Fillastre JP; Fourtillan JB; Leroy A; Ramis N; Lefevre MA; Reumont G; Humbert G
    J Antimicrob Chemother; 1986 Aug; 18(2):203-11. PubMed ID: 3759731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biapenem pharmacokinetics in healthy volunteers and in patients with impaired renal function.
    Koeppe P; Höffler D; Fitzen B
    Arzneimittelforschung; 1997 Nov; 47(11):1250-6. PubMed ID: 9428983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label, non-randomised, phase 1, single-dose study to assess the pharmacokinetics of ceftaroline in patients with end-stage renal disease requiring intermittent haemodialysis.
    Sunzel M; Learoyd M; Li J; Li Y; Ngo N; Edeki T
    Int J Antimicrob Agents; 2015 Dec; 46(6):682-8. PubMed ID: 26545441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of tocainide in patients with renal dysfunction and during haemodialysis.
    Wiegers U; Hanrath P; Kuck KH; Pottage A; Graffner C; Augustin J; Runge M
    Eur J Clin Pharmacol; 1983; 24(4):503-7. PubMed ID: 6407848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of netilmicin in renal insufficiency and haemodialysis.
    Pechere JC; Dugal R; Pechere MM
    Clin Pharmacokinet; 1978; 3(5):395-406. PubMed ID: 699461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Pharmacokinetics of Levornidazole in Elderly Subjects and Dosing Regimen Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis.
    Guo B; He G; Wu X; Yu J; Cao G; Li Y; Fan Y; Chen Y; Shi Y; Zhang Y; Zhang J
    Clin Ther; 2017 Jul; 39(7):1336-1346. PubMed ID: 28619503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.